Friedreich ataxia (FRDA) is an autosomal recessive degenerative disease characterized by relentlessly progressive gait and limb ataxia, absent tendon reflexes in the legs, electrophysiological evidence of axonal sensory neuropathy, hypertrophic cardiomyopathy, skeletal deformities, and increased risk of diabetes mellitus. Age of onset is usually before 25. Almost all patients are chairbound by the age of 45 years and no cure is available. The FRDA gene encodes a 210-aminoacid mitochondrial protein called frataxin. The most common mutation causing FRDA is the hyperexpansion of an intronic polymorphic GAA triplet repeat. As a consequence of the expansion, frataxin gene expression is reduced. Larger GAA expansion sizes correlate with earlier onset and increased severity of disease. Disruption of the yeast frataxin homolog gene (YFH1) impairs oxidative phosphorylation, causes mitochondrial iron accumulation and hypersensitivity to oxidative stress. Similar abnormalities may be occurring in the human disease. The present proposal encompasses the study of the molecular pathogenesis of FRDA from the DNA level to the clinical phenotype. The stability of GAA repeats of different length and orientation and their effect on the expression of a reporter gene will be evaluated in transgenic mice. An animal model of the disease will be established by generating frataxin-deficient mice. The molecular mechanisms of frataxin function, the perturbations to cell homeostasis that follow its deficiency, and the possibilities of pharmacological correction will be investigated in cultured cells and in the animal models. Pathological specimens from FRDA patients will be analyzed for evidence of mitochondrial iron accumulation, of oxidative damage, and of mitochondrial damage. Genotype-phenotype studies will be extended in order to: i) define the clinical variability and the core features of FRDA; ii) investigate in more detail the relation between GAA expansions, frataxin point mutations and clinical phenotype; iii) obtain additional population genetics data; iv) define the indications and limitations of genetic testing.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS034192-05
Application #
6187921
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Spinella, Giovanna M
Project Start
1995-09-30
Project End
2001-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
5
Fiscal Year
2000
Total Cost
$182,613
Indirect Cost
Name
University of Montreal
Department
Type
DUNS #
207622838
City
Montreal
State
PQ
Country
Canada
Zip Code
H3 3-J7
Coppola, Giovanni; Marmolino, Daniele; Lu, Daning et al. (2009) Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia. Hum Mol Genet 18:2452-61
Coppola, Giovanni; Choi, Sang-Hyun; Santos, Manuela M et al. (2006) Gene expression profiling in frataxin deficient mice: microarray evidence for significant expression changes without detectable neurodegeneration. Neurobiol Dis 22:302-11
Miranda, Carlos J; Santos, Manuela M; Ohshima, Keiichi et al. (2004) Frataxin overexpressing mice. FEBS Lett 572:281-8
Santos, Manuela M; Miranda, Carlos J; Levy, Joanne E et al. (2003) Iron metabolism in mice with partial frataxin deficiency. Cerebellum 2:146-53
Santos, M M; Ohshima, K; Pandolfo, M (2001) Frataxin deficiency enhances apoptosis in cells differentiating into neuroectoderm. Hum Mol Genet 10:1935-44
Jiralerspong, S; Ge, B; Hudson, T J et al. (2001) Manganese superoxide dismutase induction by iron is impaired in Friedreich ataxia cells. FEBS Lett 509:101-5
Sakamoto, N; Larson, J E; Iyer, R R et al. (2001) GGA*TCC-interrupted triplets in long GAA*TTC repeats inhibit the formation of triplex and sticky DNA structures, alleviate transcription inhibition, and reduce genetic instabilities. J Biol Chem 276:27178-87
Sakamoto, N; Ohshima, K; Montermini, L et al. (2001) Sticky DNA, a self-associated complex formed at long GAA*TTC repeats in intron 1 of the frataxin gene, inhibits transcription. J Biol Chem 276:27171-7
Labuda, M; Labuda, D; Miranda, C et al. (2000) Unique origin and specific ethnic distribution of the Friedreich ataxia GAA expansion. Neurology 54:2322-4
Cossee, M; Durr, A; Schmitt, M et al. (1999) Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol 45:200-6

Showing the most recent 10 out of 25 publications